Jazz Pharmaceuticals plc — Director's Dealing 2015

May 28, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-05-26

Reporting Person: McGill Iain (SVP, Europe and Rest of World)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-26	Ordinary Shares	M	5834.0	$46.83	Acquired	30530	Direct
2015-05-26	Ordinary Shares	M	1500.0	$59.13	Acquired	32030	Direct
2015-05-26	Ordinary Shares	S	7334.0	$179.4827	Disposed	24696	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-26	Non-Qualified Stock Option (right to buy)	$46.83	M	5834.0	Disposed	2022-08-08	Ordinary Shares (5834)	Direct
2015-05-26	Non-Qualified Stock Option (right to buy)	$59.13	M	1500.0	Disposed	2023-03-04	Ordinary Shares (1500)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.17 to $179.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F2: Following the reported transaction, the remaining ordinary shares subject to this option vest in equal monthly installments from June 9, 2015 to August 9, 2016.

F3: Following the reported transaction, the remaining ordinary shares subject to this option vest in equal monthly installments from June 5, 2015 to March 5, 2017.